Statistics

Total Visits

Views
Phase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer81

Select a period of time:

Number of views in the range

Views
Phase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer19

Views

Views
June 20253
July 202510
August 20251
September 20251
October 20251
November 20253
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Brazil5
United Kingdom3
Colombia1
 

Top cities views

Views
Dallas2
Brasília1
Cachoeirinha1
Erie1
Fortaleza1
Marabá1
Palmares do Sul1
San Antonio1
Santiago de Cali1
Wallingford1